Evidence map›Paper›PMID 23836053›Full record

ArticleCancer causes & control : CCC2013

Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics.

Anand P Chokkalingam, Ling-I Hsu, Catherine Metayer, Helen M Hansen, Stacy R Month, Lisa F Barcellos, Joseph L Wiemels, Patricia A Buffler

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Cancer causes & control : CCC, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. ARID5B gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a meta-analysis based on 39,116 subjects.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  11. Article
  12. Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Review
  13. Genetic susceptibility in childhood acute lymphoblastic leukemia.Medical oncology (Northwood, London, England) · 2017
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Genetic and nongenetic risk factors for childhood cancer.Pediatric clinics of North America · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anand P ChokkalingamDivision of Epidemiology, School of Public Health, University of California, 1995 University Ave, Ste 460, Berkeley, CA, 94704, USA, anandc@berkeley.edu.
Ling-I Hsu
Catherine Metayer
Helen M Hansen
Stacy R Month
Lisa F Barcellos
Joseph L Wiemels
Patricia A Buffler
University of California System · USKaiser Permanente · USUniversity of California, San Francisco · US

Funding

Training CoreP42ES004705 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MCHALE, CLIONA · 1987 to 2025
$74.6M
Environmental and Molecular Epidemiology of Childhood LeukemiaR01ES009137 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI METAYER, CATHERINE · 1999 to 2013
$21.1M
Cancer Research UK 2005/027Cancer Research UK 2005/028Cancer Research UK 2006/053NIEHS NIH HHS P42 ES004705NIEHS NIH HHS PS42ES04705NIEHS NIH HHS R01 ES009137NIEHS NIH HHS R01ES09137
6 · The paper itself

Abstract

Recent genome-wide studies conducted in European Whites have identified novel susceptibility genes for childhood acute lymphoblastic leukemia (ALL). We sought to examine whether these loci are susceptibility genes among Hispanics, whose reported incidence of childhood ALL is the highest of all ethnic groups in California, and whether their effects differ between Hispanics and non-Hispanic Whites (NHWs). We genotyped 13 variants in these genes among 706 Hispanic (300 cases, 406 controls) and 594 NHW (225 cases, 369 controls) participants in a matched population-based case-control study in California. We found significant associations for the five studied ARID5B variants in both Hispanics (p values of 1.0 × 10(-9) to 0.004) and NHWs (p values of 2.2 × 10(-6) to 0.018). Risk estimates were in the same direction in both groups (ORs of 1.53-1.99 and 1.37-1.84, respectively) and strengthened when restricted to B-cell precursor high-hyperdiploid ALL (>50 chromosomes; ORs of 2.21-3.22 and 1.67-2.71, respectively). Similar results were observed for the single CEBPE variant. Hispanics and NHWs exhibited different susceptibility loci at CDKN2A. Although IKZF1 loci showed significant susceptibility effects among NHWs (p < 1 × 10(-5)), their effects among Hispanics were in the same direction but nonsignificant, despite similar minor allele frequencies. Future studies should examine whether the observed effects vary by environmental, immunological, or lifestyle factors.

Indexed as

CaliforniaCase-Control StudiesCCAAT-Enhancer-Binding ProteinsChildChild, PreschoolDNA-Binding ProteinsFemaleGene FrequencyGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyGenotypeHispanic or LatinoHumansMalePrecursor Cell Lymphoblastic Leukemia-LymphomaARID5B protein, humanCCAAT-Enhancer-Binding ProteinsCEBPE protein, humanDNA-Binding ProteinsTranscription Factors

Identifiers

PMID23836053
PMCPMC3771434
OpenAlexW2027469206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.